Immune reconstitution
Showing 26 - 50 of >10,000
Recurrent Melanoma, Stage IV Melanoma Trial in Rochester (drug, other, procedure)
Completed
- Recurrent Melanoma
- Stage IV Melanoma
- temozolomide
- +4 more
-
Rochester, MinnesotaMayo Clinic
Sep 28, 2020
Myelodysplastic Syndrome, Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia Trial in Washington, Bethesda, Oklahoma City
Completed
- Myelodysplastic Syndrome
- +4 more
- First Allogeneic Bone Marrow Transplant (BMT)
- +9 more
-
Washington, District of Columbia
- +2 more
Mar 16, 2021
Human Immunodeficiency Virus Infection Trial in Sacramento (darunavir with ritonavir and fixed-dose viread+emtricitabine daily)
Completed
- Human Immunodeficiency Virus Infection
- darunavir with ritonavir and fixed-dose viread+emtricitabine daily
-
Sacramento, CaliforniaUniversity of California Davis
Feb 24, 2020
Hematological Malignancies Trial (Allogeneic T cell progenitors, cultured ex-vivo)
Not yet recruiting
- Hematological Malignancies
- Allogeneic T cell progenitors, cultured ex-vivo
- (no location specified)
Mar 2, 2023
Immune Reconstitution Syndrome in HIV-Infected Patients Taking
Completed
- Immune Reconstitution Inflammatory Syndrome
-
Bethesda, Maryland
- +2 more
Oct 4, 2019
Donor COVID-19 Infection Status on the Recipient in Allo-HSCT
Recruiting
- COVID-19
- Hematopoietic Stem Cell Transplantation
-
Suzhou, Jiangsu, ChinaFirst Affiliated Hospital of Soochow University
Jan 10, 2023
Primary HIV-1 Drug Resistance Mutations on Immune Reconstruction
Not yet recruiting
- Hiv
- +5 more
- differences in CD4 reconstruction
- (no location specified)
Sep 17, 2023
Patients With MDS, Acute Myeloid Leukemia (AML) Evolving From MDS, and Chronic Myelomonocytic Leukemia (CMML) Trial in Seoul
Active, not recruiting
- Patients With MDS, Acute Myeloid Leukemia (AML) Evolving From MDS, and Chronic Myelomonocytic Leukemia (CMML)
-
Seoul, Korea, Republic ofAsan Medical Center, University of Ulsan College of Medicine
Oct 19, 2023
Acute Leukemia Trial (Rifaximin with allogeneic stem cell transplant, Allogeneic stem cell transplant)
Not yet recruiting
- Acute Leukemia
- Rifaximin with allogeneic stem cell transplant
- Allogeneic stem cell transplant
- (no location specified)
Sep 21, 2023
Human Immunodeficiency Virus, Disorder of Immune Reconstitution Trial in Beijing (Conventional plus AAIT)
Recruiting
- Human Immunodeficiency Virus
- Disorder of Immune Reconstitution
- Conventional plus AAIT
-
Beijing, Beijing, ChinaBeijing 302 hospital
Jun 17, 2019
AML/MDS Trial in Copenhagen (iDLI)
Recruiting
- AML/MDS
- iDLI
-
Copenhagen, DenmarkCopenhagen University Hospital, Rigshospitalet
Jan 13, 2023
Acute Leukemia, Acute Myeloid Leukemia, MDS Trial in Philadelphia (CliniMACS Cell Processing System for TCRaß + T Cell and
Recruiting
- Acute Leukemia
- +7 more
- CliniMACS Cell Processing System for TCRαβ + T Cell and CD45RA Depleted Peripheral Stem Cell Addback
-
Philadelphia, PennsylvaniaChildren's Hospital of Philadelphia
Mar 21, 2022
Adenovirus, Cytomegalovirus Infections, Epstein-Barr Virus Infections Trial in Pittsburgh (Specific T- Lymphocytes)
Not yet recruiting
- Adenovirus
- +2 more
- Specific T- Lymphocytes
-
Pittsburgh, PennsylvaniaUPMC Children's Hospital of Pittsburgh
Sep 8, 2023
Congenital Athymia Patient Registry
Recruiting
- Complete DiGeorge Anomaly
- +2 more
- Cultured Thymus Tissue
-
Durham, North CarolinaDuke University School of Medicine
Apr 18, 2022
The Optimization of Haploidentical Hematopoietic Stem Cell
Not yet recruiting
- Hematological Malignancy
- ATG
- Post-transplantation cyclophosphamide
-
Beijing, Beijing, ChinaPeople's Hospital of Peking University
Nov 28, 2022
Aplastic Anemia, Bone Marrow Failure Syndrome Trial in Memphis (drug, radiation, device, biological)
Recruiting
- Aplastic Anemia
- Bone Marrow Failure Syndrome
- Anti-Thymocyte Globulin (Rabbit)
- +8 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Aug 26, 2022
Multiple Sclerosis, Progressive Multifocal Leukoencephalopathy Trial run by the National Institute of Neurological Disorders and
Not yet recruiting
- Multiple Sclerosis
- Progressive Multifocal Leukoencephalopathy
- 89 Zr-Df-crefmirlimab
-
Bethesda, MarylandNational Institutes of Health Clinical Center
May 13, 2023
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Duarte (Biospecimen Collection, Chest
Not yet recruiting
- Acute Lymphoblastic Leukemia
- +2 more
- Biospecimen Collection
- +7 more
-
Duarte, CaliforniaCity of Hope Medical Center
Nov 9, 2023
Alterations in Intestinal Microbiota, Metabolites, and Immune
Recruiting
- Graft Vs Host Disease
- Blood Sample
- +2 more
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University
Nov 16, 2023
Chronic Granulomatous Disease Transplant Trial run by the NIAID (drug, radiation, biological)
Active, not recruiting
- Chronic Granulomatous Disease Transplant
- Alemtuzumab
- +5 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 21, 2023
Adenosine Deaminase Severe Combined Immune Deficiency Trial (A cryopreserved formulation of autologous mPB CD34+ hematopoietic
Not yet recruiting
- Adenosine Deaminase Severe Combined Immune Deficiency
- A cryopreserved formulation of autologous mPB CD34+ hematopoietic stem and progenitor cells transduced ex vivo with the EFS-ADA lentiviral vector encoding the human ADA enzyme
- (no location specified)
Jun 20, 2022
Myelodysplasia, Hematologic Malignancy Trial in Columbus (CliniMACS® TCRaß/CD19 Combined Depletion System)
Recruiting
- Myelodysplasia
- Hematologic Malignancy
- CliniMACS® TCRαβ/CD19 Combined Depletion System
-
Columbus, OhioNationwide Children's Hospital
Jan 11, 2022
Hematologic Diseases Trial in Palo Alto (biological, device, drug)
Recruiting
- Hematologic Diseases
- Allogeneic Stem Cell Transplant
- +2 more
-
Palo Alto, CaliforniaLucile Packard Children's Hospital
Mar 25, 2022